MedTech Week Magazine 2019 At a glance

Highlights from the 5th Edition of the Award-Winning MedTech Week Magazine

social white padded



I am particularly pleased to see so many examples of companies reaching out to their communities and engaging with employees – after all, medtech is really about people rather than technology.

Serge Bernasconi
Chief Executive, MedTech Europe
map box







twitter white


new fans & followers


website visits


video views

Bringing Sound & Vision to the message

Search MedTech Week magazine
Or filter articles & perspectives by tags
  • Patient
  • Expert
  • Value of medtech
  • Digital Health
  • Innovation
  • Career and education
  • Antimicrobial Resistance (AMR)
  • Regulations and legal
  • Cardiology
  • Orthopheadic
  • Homecare
  • Diagnostics
  • Diabetes


Perspectives New role for Clinical Research Organisations
Regulations and legal, Expert

New role for Clinical Research Organisations

Two new EU Regulations will require the collection and analysis of more data during clinical investigations

Perspectives Green is the new black
Value of medtech, Expert

Green is the new black

Climate action is rightfully gaining space on the policy agenda. Healthcare is part of the problem and must become part of the solution.

Perspectives Improving the lives of people living with diabetes
Diabetes, Expert

Improving the lives of people living with diabetes

It is incredible when I think that nearly 100 years have passed since the discovery of insulin. Since then, insulin has saved the lives of millions of people living with diabetes around the world.

Perspectives What do patients want
Diagnostics, Expert

What do patients want?

Patients don’t care about technology – they care about the quality of life

Perspectives Career inspiration My journey in biomedical engineering
Career and education, Expert

Career inspiration: My journey to biomedical engineering

At the age of seventeen, I was good at maths and sciences, but I did not know what to study after secondary school.

Perspectives Are you ready for Eudamed
Regulations and legal, Expert

Are you ready for Eudamed?

One of the biggest changes on the healthcare horizon will be new EU requirements for product information. If you are not already preparing for this, start now – the clock is ticking.

Perspectives Changing health changing lives
Value of medtech, Expert

Changing health, changing lives

Our sector has changed a great deal in the last decade, but there is much more innovation to come – notably in customisation and data.

Perspectives Incontinence  Breaking the taboo
Value of medtech, Expert

Incontinence: Breaking the taboo

The condition can be treated, often cured, and always managed

Perspectives Will it make the boat go faster
Value of medtech, Expert

‘Will it make the boat go faster?’

We need to work in partnership with healthcare providers to understand the true value of technologies.

Perspectives The future of medicine is personal
Value of medtech, Expert

The future of medicine is personal

We must all play our part in embedding personalised medicine into Europe’s healthcare systems

Fighting antimicrobial resistance (AMR)

Diagnostic tests are the invisible heroes of the healthcare system. Between 60 and 70% of all medical decisions are based on the results of diagnostic tests, but medical biology represents only 2-3% of healthcare expenditures.

In vitro diagnostic (IVD) tests help clinicians make decisions that improve patient care and better manage healthcare costs. For example, IVDs can identify which micro-organism is causing an infection, and guide timely and accurate treatment choices.

The emergence of new bacterial strains, known as ‘superbugs’, which are resistant to nearly all antibiotics, are a major threat to patients and could make straightforward surgical procedures a serious infection risk. Not only is this a problem in hospitals, but superbugs are increasingly found in the wider community.

Misuse and overuse of antibiotics is a crucial factor in the development of AMR. For example, patients are sometimes given antibiotics for viral illnesses or are prescribed the wrong antibiotic for their bacterial infection.

Diagnostic tests have an impact at both individual and collective levels, by contributing to the protection and the improvement of public health. By diagnosing the cause of an infection, clinicians can select the appropriate treatment and play their part in antibiotic stewardship.

bioMérieux ran a social media campaign throughout European during MedTech Week 2019 that put the spotlight on the medical and economic value of diagnostics. The campaign also promoted the fight against AMR thanks to the responsible use of antibiotics. It also highlighted the importance of innovation and education to curb this public health threat and sustain antibiotic efficacy for future generations.

In particular, the company is playing its part in driving public-private collaboration in the field. The VALUE-Dx project, a consortium of 26 partners co-led by bioMérieux, aims to demonstrate the medical and economic value of diagnostics to combat AMR by optimizing antibiotic use. This project is EU funded through the Innovative Medicines Initiative (IMI) joint undertaking.



company badge

Medtech Week magazine archive

Click on the covers to view full magazine online